Rheumatoid arthritis is a more severe, but less common, form of arthritis than osteoarthritis. It occurs when the body’s immune system attacks and destroys the affected joints, causing pain and swelling to occur. This can lead to a reduction in movement and the breakdown of bone and cartilage.
The research team compared the DNA of arthritis patients with those without the disease and found 42 “faulty” areas that were linked with the disease. According to the BBC, the hope is that, long-term, drugs can be developed to compensate for these faults.
The research was carried out at the Harvard Medical School and the findings have been published in the journal Nature. The paper is titled “Rheumatoid arthritis research shows potential of large-scale genetic studies for drug discovery.”